Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals

Thess, Andreas, Grund, Stefanie, Mui, Barbara L, Hope, Michael J, Baumhof, Patrick, Fotin-Mleczek, Mariola, Schlake, Thomas·2015·Molecular Therapy
DOI 10.1038/mt.2015.103

Cited by (514)

Items 401–500 of 514

  1. Smart dendrimer nanogels boost mRNA-based cancer therapy via synergistic glycolysis inhibition and immune activation
    Xianghao Xiao, Yue Gao, Aojie Li, Yiyang Jia, Jingjing Li, Mengjiao Zhang, Ruiqi Ji, Mingwu Shen, Andrij Pich, Xiangyang Shi · 2025 · Bioactive Materials
  2. From RNA to DNA: How Cargo Identity Reprograms Lipid Nanoparticle Architecture and Function
    Erica Quagliarini, Daniela Pozzi, Giulio Caracciolo · 2026 · Advanced Healthcare Materials
  3. Beyond the Sequence: Chemical and Topological Design and Innovations in mRNA Therapeutics
    Dangliang Liu, Hongyu Chen, Alisia Pan, Xiao Wang · 2026 · Chemical Reviews
  4. Oligonucleotide therapeutics in sports? An antidoping perspective
    Maria Kristina Parr, Annekathrin M. Keiler · 2024 · Archiv der Pharmazie
  5. A pan-orthoebolavirus neutralizing antibody encoded by mRNA effectively prevents virus infection
    Pengfei Fan, Bingjie Sun, Zixuan Liu, Ting Fang, Yi Ren, Xiaofan Zhao, Zhenwei Song, Yilong Yang, Jianmin Li, Changming Yu et al. · 2024 · Emerging Microbes & Infections
  6. A review of advances in in vitro RNA preparation by ssRNAP
    Yuan Shen, Dong-Qi Yang, Yuan Liu, Jia-En Lao, Chunqing Liu, Xiaoya Gao, Yun-Ru He, Heng Xia · 2025 · International Journal of Biological Macromolecules
  7. Supramolecular Gene Transfection Agents
    Bruno Pitard, Damien Habrant · 2016 · Elsevier eBooks
  8. Molecular dynamics simulations on the interactions between nucleic acids and a phospholipid bilayer
    Yao Xu, Shu-Wei Huang, Hong‐Ming Ding, Yu‐qiang Ma · 2023 · Chinese Physics B
  9. Advances in mRNA vaccines for viral diseases
    Yukai Huang, Xuerui Zhu, Xiao Guo, Yuancheng Zhou, Dongying Liu, Jingrui Mao, Yongai Xiong, Youcai Deng, Xinghong Gao · 2023 · Journal of Medical Virology
  10. Effects on hepatic lipid metabolism in human hepatoma cells following overexpression of TGFβ induced factor homeobox 1 or 2
    Jennifer Härdfeldt, Leanne Hodson, Lilian Larsson, Matteo Pedrelli, Camilla Pramfalk · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  11. The Advances of Biomacromolecule-based Nanomedicine in Brain Disease
    Yuhua Weng, Yuanyu Huang · 2019 · Springer eBooks
  12. Engineering Anti-Tumor Immunity: An Immunological Framework for mRNA Cancer Vaccines
    Olivia Roy, Karen S. Anderson · 2025 · Vaccines
  13. In silico analysis of VEGFR2 and c-MET in consideration with immunologic facts: Implications for mRNA vaccine design against breast cancer
    Marziyeh Ghayoumian, Fahimeh Shamsi, Hamid Madanchi, Mohammad Mehdi Ranjbar, Reza Jalalirad, Ramin Sarrami‐Forooshani, Mehdi Mahdavi · 2025 · International Immunopharmacology
  14. Sequence simplification of antigen coding IVT mRNA allows accelerated synthetic DNA template generation and epitope immunogenicity validation
    Arthur Esprit, Dorien Autaers, Ilke Aernout, Ine Lentacker, Steve Pascolo, Kris Thielemans, Karine Breckpot, Lorenzo Franceschini · 2025 · Molecular Therapy — Nucleic Acids
  15. RNA ImmunoGenic Assay: Simple method for detecting immunogenicity of in vitro transcribed mRNA
    A.K.M. Ashiqul Haque, Petra Weinmann, Sumit Biswas, Rupert Handgretinger, Markus Mezger, Michael Kormann, Justin S. Antony · 2020 · Advances in Cell and Gene Therapy
  16. The link between genetic variation and variability in vaccine responses: a narrative review
    Yingtian Zhang, Mingzhe Zhao, Wei Zhou, Luan Chen, Mo Li, Bixuan Jiang, Xianglong Zhao, Hao Wu, Lu Shen, Na Zhang et al. · 2022 · Journal of Bio-X Research
  17. The Role and Therapeutic Potential of Non-coding RNAs in Resistance to EGFR - TKIs Targeted Therapy for Non-small Cell Lung Cancer
    Yang Zhang, Ye Chen, Lili Lu, Xiuli Xie, Huan Ren, Lifang Wu, Li-Na Tan, Tao Xu, Yong Jie Jin · 2024 · Current Medicinal Chemistry
  18. An oral vaccine for SARS-CoV-2 RBD mRNA-bovine milk-derived exosomes induces a neutralizing antibody response in vivo
    Quan Zhang, Miao Wang, Chunle Han et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  19. Research advances of liposomes and exosomes in drug delivery and biomarker screening
    Yating Su, Xiaohong Qian, Weijie Qin · 2025 · Chinese Journal of Chromatography
  20. Engineering Universal Cancer Immunity: Non-Tumor-Specific mRNA Vaccines Trigger Epitope Spreading in Cold Tumors
    Matthias Magoola, Sarfaraz K. Niazi · 2025 · Vaccines
  21. Restoring Tumor Suppression Activity: Mimicking Molecules (TargomiRs and MRX34) and Synthetic RNAs (MTL-CEBPA)
    Kethavath Anjali Priya Naik, Santhosh Nayak Kethavath, K. Rosangzula, Jarpala Saikrishna, Rathod Sangeetha, Ravinder Reddy Patlolla, Ajit Hanumant Chandgude, Linga Banoth · 2026 · Springer eBooks
  22. mRNA and Peptide Vaccines in Melanoma—Current Landscape and Future Direction
    Jiaxing Jason Qin, Yang Wang, Shahneen Sandhu · 2026 · Cells
  23. Rationale for multi-epitope TGFβ vaccination in pancreatic cancer: evidence from immunologic and clinical correlates
    Josephine Hallundbæk Ruders, Shamaila Munir Ahmad, Rasmus Erik Johansson Mortensen, Özcan Met, Mikkel Byrdal, Inna Markovna Chen, Susann Theile, Morten Orebo Holmström, Mads Hald Andersen · 2026 · Signal Transduction and Targeted Therapy
  24. Immunization with PfGBP130 generates antibodies that inhibit RBC invasion by P. falciparum parasites
    Yannick Johnson, Ahmad Rushdi Shakri, Sunthorn Pond‐Tor et al. · 2024 · Frontiers in Immunology
  25. Harnessing dendritic cells as immunological bridges to potentiate mRNA cancer vaccines
    Ruiying Wu, Huixin Li, Ziqin Li, Kai Hao, Huayu Tian · 2025 · Journal of Materials Chemistry B
  26. Measuring Hematocrit in Mice Injected with In Vitro-Transcribed Erythropoietin mRNA
    Azita J. Mahiny, Katalin Karikó · 2016 · Methods in molecular biology
  27. A Historical Overview on mRNA Vaccine Development
    Rein Verbeke, Miffy H. Y. Cheng, Pieter R. Cullis · 2024 · Wiley eBooks
  28. Novel ATP-Responsive polyamidoamine-polyethyleneimine dendrimers for enhanced gene delivery: A potential therapy for fibroproliferative scars
    Hamid Noury, Abbas Rahdar, Luiz Fernando Romanholo Ferreira, Zahra Jamalpoor · 2025 · Journal of Drug Delivery Science and Technology
  29. Pioneering next-generation mRNA therapeutics through molecular engineering and delivery optimization
    Lin Qi, Zhihong Li, Zunyong Feng, Jianping Liu, Xiaoyuan Shawn Chen · 2025 · Materials Today
  30. The Evolving Landscape of mRNA Therapeutics: From Molecular Design and Advanced Delivery Systems to Clinical Translation and Future Vistas
    Ebrahim Sadaqa, Adam Arditya Fajriawan, Sjaikhurrizal El Muttaqien · 2026 · Biointerface Research in Applied Chemistry
  31. A novel mRNA-based multiepitope vaccine candidate against Cryptosporidium hominis and Cryptosporidium parvum employing reverse-vaccinology and immunoinformatics approaches
    Ahmad Abdullah Mahdeen, Imam Hossain, Md. Habib Ullah Masum, T M Fazla Rabbi, Md. Sajedul Islam · 2026 · PLoS ONE
  32. Lipid-based Nanocarriers for mRNA Delivery: Vital Considerations and Applications
    Teenu Sharma, Marianesan Arockia Babu, Atul Jain, Deepika Sharma · 2024 · Nanoscience & Nanotechnology-Asia
  33. Points-to-consider: the mRNA vaccine reflection paper
    Teruhide Yamaguchi, Takashi Ogawa, Tsuyoshi ANDO, Satoshi Yoshida, Akira Sakurai, Kazushige Maki, Yasuhiro Araki · 2024 · Translational and Regulatory Sciences
  34. Antitumor mRNA vaccines based on neoantigens
    Ekaterina V. Starostina, L. F. Nizolenko, Л. И. Карпенко, A. A. Ilyichev · 2025 · Siberian Journal of Oncology
  35. mRNA Technology a Promising Strategy for Rapid Response Vaccine Applications against the Emerging Infectious Diseases
    Anju Kaushal · 2021 · ACTA SCIENTIFIC MICROBIOLOGY
  36. Vaccines: past, present and future
    Ion Berdeu, Diana Spătaru, Angela Paraschiv · 2021 · One Health & Risk Management
  37. Biofunctionalized mesoporous silica nanocarriers and the applications in tumor therapy
    Xiaoni Wang, Juanjuan Wei, Jin Ouyang, Na Na · 2022 · Chinese Science Bulletin (Chinese Version)
  38. Recent Update of COVID-19 Vaccines
    Sameer A. Jadaan, Abdul Waheed Khan · 2021 · Advanced Pharmaceutical Bulletin
  39. A 10-valent composite mRNA vaccine against both influenza and COVID-19
    Yang Wang, Qinhai Ma, Man Li, Qianyi Mai, Lin Ma, Hong Zhang, Huiling Zhong, Nan Cheng, Pei Feng, Peikun Guan et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  40. mRNA vaccines for COVID-19
    Anamika Sengupta · 2022 · Elsevier eBooks
  41. Sequence-Optimized mRNA Vaccines Against Infectious Disease
    Susanne Rauch, Johannes Lutz, Janine Mühe, Aleksandra Kowalczyk, Thomas Schlake, Regina Heidenreich · 2024 · Methods in molecular biology
  42. Global research hotspots and trends of the vaccines: Based on ESI hot papers
    Meixin He, Runfeng Shi, Huilin Cao, Yuyu Wang, Yue Zhu, Xinyu Wang, Liming Liang, Xia Xu · 2025 · Human Vaccines & Immunotherapeutics
  43. Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a fatty acid binding protein vaccine
    Javier Sánchez‐Montejo, Cristina Teodósio, Tania Strilets, Julio López‐Abán, Raúl Manzano-Román, Julio Pozo, Silvia Martín, Lidia Silos, Ignacio Trujillo-Rodríguez, Mariano A. García-Blanco et al. · 2025 · Frontiers in Immunology
  44. Influenza A virus derived NS1 enhances translation of HPLC purified mRNA and interferon adjuvanted mRNA vaccination
    Kyle K.L. Phua, Yi Liu, Wei Zhang, Jas Min Chin, Hong-Wen Tang, Norbert Pardi, Smita K. Nair · 2026 · Scientific Reports
  45. mRNA vaccines in cancer immunotherapy: current progress and perspectives in solid tumors and hematologic malignancies
    N Qiao, Jingxian Chen, Yan Liu, Z. Jeffrey Chen, S. -J. Chen · 2026 · MedScience
  46. From Global Insights to Local Action: Bridging Vaccine Design and Manufacturing Gaps in H5N1 Pandemic Readiness
    María Alicia Delfino, Jimena Borgo, Luciano Chaneton, Natacha Cerny, Augusto E. Bivona, Pierre Gsell, Fernando Lobos, Ike James, Martin Friede, Germán Sanchez Alberti et al. · 2026 · Vaccines
  47. Perspective Chapter: Next-Generation Vaccines Based on Self-Amplifying RNA
    Fatemeh Nafian, Simin Nafian, Ghazal Soleymani, Zahra Pourmanouchehri, Mahnaz Kiyanjam, Sharareh Berenji Jalaei, Hanie Jeyroudi, Sayed Mohammad Mohammdi · 2021 · IntechOpen eBooks
  48. Advances in mRNA Delivery and Clinical Applications
    Bo Hu, Abid Hussain, Qing Lin Liu, Yuhua Weng, Yuanyu Huang · 2022 · RNA technologies
  49. Codon Optimality Modulates Cellular Stress and Innate Immune Responses Triggered by Exogenous RNAs
    Chotiwat Seephetdee, Nada Bejar, Kathrina Castillo, Eric P. Chau, Thy Y. Nguyen, Biana Godin, Dániel Kiss · 2026 · Journal of Molecular Biology
  50. Just the messenger
    Amanda B. Keener · 2018 · Nature Medicine
  51. Application of quantitative and engineering biology in mRNA gene therapy
    Hong Xiang, Lei Ke, Xiaohu Yang, Jianmin Guo, Wei Yang, Yong Hu · 2020 · Chinese Science Bulletin (Chinese Version)
  52. pDNA and mRNA vaccines
    Kanwal Gill, Leanne Minall, Aslin Rodríguez Nassif · 2021 · Elsevier eBooks
  53. A Peptide Barcode Based Approach for Efficient in vivo Screening of RNA Delivery Systems
    Uchechukwu Odunze, Nitin Rustogi, Paul Devine, Lorraine Miller, Sara Pereira, Surender Vashist, Arjan Snijder, Dominic J. Corkill, Alan Sabirsh, Julie A. Douthwaite et al. · 2023 · Research Square
  54. Transient growth factor expression via mRNA in lipid nanoparticles promotes hepatocyte cell therapy to treat murine liver diseases
    Anna R. Smith, Fatima Rizvi, Elissa Everton, Anisah Adeagbo, Susan Y. Wu, Ying K. Tam, Hiromi Muramatsu, Norbert Pardi, Drew Weissman, Valerie Gouon–Evans · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  55. Modified or Unmodified mRNA Vaccines? – The Biochemistry of Pseudouridine and mRNA Pseudouridylation
    Pedro Morais, Yi‐Tao Yu · 2024 · Wiley eBooks
  56. Design and Development of mRNA Vaccines to Combat the COVID ‐19 Pandemic
    István Tombácz · 2024 · Wiley eBooks
  57. New Challenges In Non-Linear Signal And Image Processing
    Stephen Marshall, Edward R. Dougherty · 2004
  58. Future Horizons and New Target Class Opportunities
    Herren Wu, Carl I. Webster, Judy Paterson, Sandrine Guillard, Ron Jackson, Ralph Minter · 2017 · Methods and principles in medicinal chemistry
  59. mRNA-basierte Therapien für eine passive Immunisierung
    Moritz Thran · 2017 · BIOspektrum
  60. Lipid nanoparticles for delivery of nucleic acid therapeutics
    Sam Chen · 2017 · cIRcle (University of British Columbia)
  61. Evaluation of Biodistribution, Toxicology, and Toxicologic Pathology of Nanomaterials Used to Deliver Nucleic Acids
    H. Denny Liggitt · 2019 · Springer eBooks
  62. Deciphering the Plasmodium epitranscriptome as a mechanism of translational control
    Ameya Sinha · 2019
  63. Exigent Encounters with Vaccines Perplexes
    Sangeeta Kumari · 2021 · International Journal of Health Sciences and Research
  64. mRNA Vaccine: An Advanced and Transformative Technology for Vaccine Development
    Vikas Kushwaha, Anuprabha, R.C. Sobti · 2021 · Springer eBooks
  65. Faculty Opinions recommendation of Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose.
    Donald A. Tomalia · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  66. Messenger RNA Based Vaccines and Their immunological effect on diseases
    Osama Mohammed Hasan · 2022 · Al Mustansiriyah Journal of Pharmaceutical Sciences
  67. Broadly Neutralizing Antibodies Against Omicron Variants of SARS-CoV-2 Derived from mRNA-Lipid Nanoparticle-Immunized Mice
    Ruei‐Min Lu, Kang-Hao Liang, Hsiao-Ling Chiang et al. · 2022 · SSRN Electronic Journal
  68. Condon Optimization: Codon Optimization of Therapeutic Proteins: Suggested Criteria for Increased Efficacy and Safety
    Vincent P. Mauro · 2022 · Springer eBooks
  69. Lipid Nanoparticles to Harness the Therapeutic Potential of mRNA for Cancer Treatment
    Maria L. Guevara, Francesca Persano, Stefano Persano · 2022 · RNA technologies
  70. Synthetic mRNA Gene Therapies and Hepatotropic Non-viral Vectors for the Treatment of Chronic HBV Infections
    Dylan Kairuz, Prashika Singh, Tiffany S. Smith, Patrick B. Arbuthnot, Abdullah Ely, Kristie M. Bloom · 2022 · RNA technologies
  71. Multivalent Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccines Demonstrate a Greater Breadth in T cell but not Antibody Responses
    Hsuan-Yuan Wang, Leike Li, Cody S. Nelson, Richard Barfield, Sarah M. Valencia, Cliburn C. W. Chan, Hiromi Muramatsu, Paulo J.C. Lin, Norbert Pardi, Zhiqiang An et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  72. Agent-Based Model of the Impact of Higher Influenza Vaccine Efficacy on Seasonal Influenza Burden
    Mary G. Krauland, Richard Kent Zimmerman, Katherine V. Williams · 2022 · SSRN Electronic Journal
  73. Vaccine Design Strategies: Pathogens to Genomes
    Niall McMullan · 2021 · Royal Society of Chemistry eBooks
  74. mRNA vaccine encoding neoantigen for cancer immunotherapy using mouse melanoma as a model
    Chutamath Sittplangkoon, Tanapat Palaga · 2021 · Chula Digiverse
  75. Protein expression and inflammatory response after delivery of mRNA encoding platelet-derived growth factor-BB in sucrose citrate buffer into rat gingiva
    Phan Bhongsatiern, Wichaya Wisitrasameewong, Rangsini Mahanonda · 2019 · Chula Digiverse
  76. [Research Progress of Lung Cancer Vaccines].
    Hao Fan, Xiangwei Ge, Xin Zhou, Yao Li, An Wang, Yi Hu · 2023 · PubMed Central
  77. mRNA vaccines: a promising solution for incurable diseases
    Hongnuo Ge, YanYuen Hei, Jingxuan Wu · 2024 · International Conference on Biological Engineering and Medical Science (ICBioMed)
  78. mRNA Vaccines in Treatment Tumor: Advancement and Challenges
    Wen Cao · 2024 · Transactions on Materials Biotechnology and Life Sciences
  79. It is all in the delivery
    Jasmine E. Francis, Peter M. Smooker · 2024 · Elsevier eBooks
  80. mRNA Vaccine: The Starting Point of the Human Body Revolution
    Wenhao Jiang · 2024 · Highlights in Science Engineering and Technology
  81. Formulations and mechanisms of action of novel vaccine adjuvants
    Susu M. Zughaier, Amna Hashim, Nidal H. Khodr, Abdul Rahman Al Abiad, Mohannad Natheef AbuHaweeleh · 2024 · Elsevier eBooks
  82. mRNA vaccines: the next frontier in disease prevention
    Quratul ain Babar, Maryam Maryam, ALI MUSTAPHA MUHAMMAD, Muhammad Farrukh Tahir, Anwar Mohamed Ali · 2024 · Elsevier eBooks
  83. RNA Therapies in Cancer
    Fatemeh Khatami, Setareh Zahedian, Leila Zareian Baghdadabad, Rahil Mashhadi, Mandana Hasanzad, Zeinab Ahadi, Seyed Mohamamd Kazem Aghamir · 2024 · Springer eBooks
  84. Advances in the development of therapeutic mRNA vaccines for cancer therapy
    Kexin Deng, Xiaobin Li, Wanwan Liu, Junyu Liu, Runming Wang, Yandong Yin, Can Yang Zhang · 2024 · Chinese Science Bulletin (Chinese Version)
  85. Cancer Vaccines Based on mRNA: Hype or Hope?
    Wout de Mey, Dorien Autaers, Giada Bertazzon, Arthur Esprit, Marta Marco Aragon, Lorenzo Franceschini, Karine Breckpot · 2024 · Wiley eBooks
  86. mRNA vaccines: The new frontier
    Zhipeng Yan, Ming Jin Yang, Elaine Tian, Ching‐Lung Lai · 2025 · Elsevier eBooks
  87. mRNA Vaccines: Unlocking Potential, Exploring Applications, and Envisioning Future Horizons
    Gaurav Mishra, Sunny Rathee, Munish Garg, Umesh Kumar Patil · 2025 · Current Drug Delivery
  88. mRNA-Based Biosimilars as Next-Generation Vaccines
    Anam Upadhyay, Vibha Rani · 2025 · Advances in Science, Technology & Innovation/Advances in science, technology & innovation
  89. Awakening Sleeping Beauties from articles on mRNA vaccines against COVID-19
    Artemis Chaleplioglou, Efstathia Selinopoulou, Konstantinos Kyprianos, Alexandros Koulouris · 2026 · Scientometrics
  90. Application of synthetic biology in vaccine development
    Ayon Dutta, Dipanjana Ash, Biswajit Basu, Bhupendra Gopalbhai Prajapati · 2025 · Elsevier eBooks
  91. Robust Functionality and Regulation of Selectively Expressed RNA as AAV Vectors and In Vitro Transcribed Molecules
    Frederik Rastfeld, Nils Hersch, Georg Dreissen, Hajaani Manoharan, Laura Wagner, Lukas Lövenich, Elke Barczak, Hildegard Büning, Rudolf Merkel, Bernd Hoffmann · 2025 · Pharmaceutics
  92. mRNA-based therapies: current progress and future prospects for treating kidney disease
    Yiyun Song, Hua Su · 2025 · Clinical and Experimental Nephrology
  93. Sensitive detection Cu/Zn SOD mRNA with CRISPR/Cas9
    Geng Qiuyu, Xing Hanxin, Cang Song, Fan Ronghua, Zheng Anqi · 2025 · Talanta Open
  94. Mannose‐Modified Cationic Liposome‐Based mRNA Therapeutics for Improved Triple‐Negative Breast Cancer Immunotherapy
    Kexin Deng, Juping Sun, Junyu Liu, Yong Zhang, Wanwan Liu, Xiaobin Li, H. T. Wu, Juan Li, Jisong Zhang, Chanyuan Jin et al. · 2025 · Advanced NanoBiomed Research
  95. mRNA Technology Beyond Vaccines: Exploring Potential mRNA-Based Therapies for Autoimmune Diseases
    Mayur Gulab Kharat, Vedangi Arvind Kulkarni, Shivani Parmeshwar Chavan, Nilesh Bhimrao Gawali, Shivali M. Khandarkar · 2026 · Asian Journal of Pharmaceutical Research
  96. Integrative bioinformatics approach to the mRNA vaccine development for the human papillomavirus using the capsid protein
    Shan He, Akmal Zubair, Faisal Ahmad, Muhammad Yaqoob Shahani, Li Zeng, Naila Afghan · 2026 · Biology Direct
  97. Recent Progress in Sequence Optimization of mRNA Vaccine: Biological Mechanism, Quantitative Metrics, and Computational Model
    Yunwei Wang, Yuheng Cai, Zhixing Wu, Jingming Zhang, Lance C. W. Turtle, Jia Meng · 2026 · Bioinformatics and Biology Insights
  98. Formulation et vectorisation d’un ARN messager vaccinal codant l’antigène Gag du VIH-1 à l’aide de nanoparticules biodégradables de poly(acide lactique)
    Anne-Line Coolen · 2018 · theses.fr (ABES)
  99. In vitro synthesis and expression validation of unmodified mRNA encoding a multi-epitope chimeric L1/L2 antigen of human papillomavirus
    Sylvere Nshimiyimana, James Hungo Kimotho, Caroline Wangare Ngugi · 2026 · Multidisciplinary Science Journal
  100. A single-nucleotide change in the Kozak sequence enhances protein expression
    Renzo A. Knol, Tahmina Fariaby, Eveline A. de Vlieger, Alexander Kros, Bram Slütter · 2026 · bioRxiv (Cold Spring Harbor Laboratory)